Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Ce.3Cl |
| Molecular Weight | 246.475 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].[Cl-].[Ce+3]
InChI
InChIKey=VYLVYHXQOHJDJL-UHFFFAOYSA-K
InChI=1S/Ce.3ClH/h;3*1H/q+3;;;/p-3
| Molecular Formula | Ce |
| Molecular Weight | 140.116 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cerous iodide is a salt of lanthanide metal cerium (III) and iodide ion. In 1920s solution of cerous iodide for intravenous injection (called "introcid") was used as an antimicrobial agent for treating puerperal fever. It has shown prophylactic activity against sepsis, and was explored for its antineoplastic properties in patients with lymphogranulomatosis or inoperable solid tumors. According to the clinical reports, it has been applied with remarkable benefit, as indicated by tumor shrinkage and improved quality of life in several cases of locally advanced or metastatic tumors of different origin.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:48:53 GMT 2025
by
admin
on
Mon Mar 31 20:48:53 GMT 2025
|
| Record UNII |
TH8E3IE00V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Cerium chloride
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY | |||
|
100000076340
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY | |||
|
232-227-8
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY | |||
|
m3266
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY | Merck Index | ||
|
35458
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY | |||
|
C026690
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY | |||
|
7790-86-5
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY | |||
|
11098-86-5
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
NON-SPECIFIC STOICHIOMETRY | |||
|
24636
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY | |||
|
84267
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY | |||
|
TH8E3IE00V
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY | |||
|
DTXSID1037199
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY | |||
|
SUB13293MIG
Created by
admin on Mon Mar 31 20:48:53 GMT 2025 , Edited by admin on Mon Mar 31 20:48:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SOLVATE->ANHYDROUS |